The greatest retrospective traumatic brain study in the last decade has been presented in RoNeuro Brain Days, which drew the attention to the positive effects of the treatment with neurotrophic factors in patients with this type of brain injuries. According to these data, the treatment significantly improves the patients' quality of life. In this complex study, coordinated by Prof. Dafin F. Mureşanu, 25 top neurosurgeons and neurologists have taken part, mostly from Romania, who have treated and monitored 7.769 patients on a period of 5 years, in 10 neurosurgery departments in Romania. During RoNeuro Brain Days, another event took place, The Congress of the European Society for Clinical Neuropharmacology (ESCNP), which is one of the elite societies of world medicine, whose president elected last year, is Prof. Dafin F. Mureşanu, MD. In addition, Prof. Mureşanu continues the projects of his predecessor, Prof. Johannes Thome, MD, from Germany, a scientific society whose purpose is the promotion of education and acquiring a high level of knowledge and understanding in the field of clinical neuropharmacology. The society supports the research activity in neuropharmacology, the development of scientific standards, counseling regarding the best methods and techniques to interpret the results but also maintaining the collaboration with the national and international societies, governmental organizations, professional associations, as well as other types of groups, societies, institutions, etc., which contribute in the development of the clinical neuropharmacology field. 
